The DOI matches its Crossref record; 46 of the 47 references it cites were found in a registry or an index.
Immunogenicity of standard and extended dosing intervals of BNT162b2 mRNA vaccine
Open accessAbstract
Extension of the interval between vaccine doses for the BNT162b2 mRNA vaccine was introduced in the United Kingdom to accelerate population coverage with a single dose. At this time, trial data were lacking, and we addressed this in a study of United Kingdom healthcare workers. The first vaccine dose induced protection from infection from the circulating alpha (B.1.1.7) variant over several weeks. In a substudy of 589 individuals, we show that this single dose induces severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) neutralizing antibody (NAb) responses and a sustained B and T cell response to the spike protein. NAb levels were higher after the extended dosing interval (6–14 weeks) compared with the conventional 3- to 4-week regimen, accompanied by enrichment of CD4 + T cells expressing interleukin-2 (IL-2). Prior SARS-CoV-2 infection amplified and accelerated the response. These data on dynamic cellular and humoral responses indicate that extension of the dosing interval is an effective immunogenic protocol.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Nonetheless, a growing number of studies suggest that an extended dosing interval amplifies both the humoral immune response30 and perhaps the cellular response,31 and is an effective global strategy given the discrepancies between regions with high and low vaccination coverage.32”
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine
Polack, F. P., Thomas, S. J., Kitchin, N., Absalon, J., Gurtman, A., Lockhart, S., Perez, J. L., Pérez Marc, G., Moreira, E. D., Zerbini, C., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2034577 · Cited by 14,592 · cited 2×
“Although Pfizer’s clinical trial described an efficacy of 52% against symptomatic infection after a single dose (Polack et al., 2020), the United Kingdom’s Joint Committee on Vaccination and Immunisation (JCVI) estimated an efficacy of 89% against symptomatic infection, having removed infection…”
BackgroundSelf-citationWhat level of neutralising antibody protects from COVID-19?
Khoury, D. S., Cromer, D., Reynaldi, A., Schlub, T. E., Wheatley, A. K., Juno, J. A., Subbarao, K., Kent, S. J., Triccas, J. A., & Davenport, M. P. (2021) · doi:10.1101/2021.03.09.21252641 · Cited by 3,742 · cited 1×
“We currently lack clear correlates of protection against SARS-CoV-2, although recent attempts to compare vaccines have given some indication of binding and neutralizing antibody measures that accompany efficacy (Earle et al., 2021; Feng et al., 2021; Khoury et al., 2021).”
Khoury, D. S., Cromer, D., Reynaldi, A., Schlub, T. E., Wheatley, A. K., Juno, J. A., Subbarao, K., Kent, S. J., Triccas, J. A., & Davenport, M. P. (2021) · Nature Medicine · doi:10.1038/s41591-021-01377-8 · Cited by 3,742
Immunological memory to SARS-CoV-2 assessed for up to 8 months after infection.
Dan, J. M., Mateus, J., Kato, Y., Hastie, K. M., Yu, E. D., Faliti, C. E., Grifoni, A., Ramirez, S. I., Haupt, S., Frazier, A., et al. (2021) · Science · doi:10.1126/science.abf4063 · Cited by 2,656 · cited 2×
“The sustained T cell response from 1 to 10 weeks after the first dose in the extended dosing interval group contrasts with the waning of T cells we and others (Dan et al., 2021; Tomic et al., 2021) have reported after natural infection.”
Rydyznski Moderbacher, C., Ramirez, S. I., Dan, J. M., Grifoni, A., Hastie, K. M., Weiskopf, D., Belanger, S., Abbott, R. K., Kim, C., Choi, J., et al. (2020) · Cell · doi:10.1016/j.cell.2020.09.038 · Cited by 1,790 · cited 1×
“Because T cells are of increasing interest for providing protection (Rydyznski Moderbacher et al., 2020; Tan et al., 2021), human data to support such a role for cellular immunity are very valuable.”
Betts, M. R., Brenchley, J. M., Price, D. A., Rosa, S. C. D., Douek, D. C., Roederer, M., & Koup, R. A. (2003) · Journal of Immunological Methods · doi:10.1016/s0022-1759(03)00265-5 · Cited by 1,587
Correlates of protection against symptomatic and asymptomatic SARS-CoV-2 infection
Feng, S., Phillips, D. J., White, T., Sayal, H., Aley, P. K., Bibi, S., Dold, C., Fuskova, M., Gilbert, S. C., Hirsch, I., et al. (2021) · Nature Medicine · doi:10.1038/s41591-021-01540-1 · Cited by 1,163
Self-citationVoysey, M., Costa Clemens, S. A., Madhi, S. A., Weckx, L. Y., Folegatti, P. M., Aley, P. K., Angus, B., Baillie, V. L., Barnabas, S. L., Bhorat, Q. E., et al. (2021) · The Lancet · doi:10.1016/s0140-6736(21)00432-3 · Cited by 1,119
Self-citationCorrelates of Protection Against SARS-CoV-2 in Rhesus Macaques
McMahan, K., Yu, J., Mercado, N. B., Loos, C., Tostanoski, L. H., Chandrashekar, A., Liu, J., Peter, L., Atyeo, C., Zhu, A., et al. (2021) · Nature · doi:10.1038/s41586-020-03041-6 · Cited by 1,068
Self-citationEvidence of escape of SARS-CoV-2 variant B.1.351 from natural and vaccine-induced sera
Zhou, D., Dejnirattisai, W., Supasa, P., Liu, C., Mentzer, A. J., Ginn, H. M., Zhao, Y., Duyvesteyn, H. M. E., Tuekprakhon, A., Nutalai, R., et al. (2021) · Cell · doi:10.1016/j.cell.2021.02.037 · Cited by 992
Self-citation
Flagged first, then by citations
1 of the 47 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
Items 301–322 of 322
Colton, H., Barratt, N., Temperton, N. J., Hornsby, H. R., Angyal, A., Grouneva, I., Lindsey, B. B., Kearns, P. R., Barnes, E. J., Goodyear, C. S., et al. (2024) · British Journal of Haematology · doi:10.1111/bjh.19874
Self-citationWang, H., Gao, H., Li, M., Cheng, L., Zhang, X., Zhang, X., Zhan, H., Liu, Y., Wang, Y., Ren, J., et al. (2024) · Journal of Proteome Research · doi:10.1021/acs.jproteome.4c00546
Virus-specific T cell response in SARS-CoV-2 infection and vaccinations
Bertoletti, A., Qui, M., & Lim, J. M. E. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-19170-1.00038-3
Jones, B., Pritchard, M. G., Paterson, A., & Rojek, A. M. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-19170-1.00029-2
Ndzouboukou, J. B., Kamara, A. A., Ullah, N., Lei, Q., & Fan, X. (2025) · Virology · doi:10.1016/j.virol.2025.110509
Ahmed, J. I., Krosta, S. J., Reimer, M. N., Cheung, W., Mesa, C., Lopez, C., Chua, R. J., Alsattari, F., Robinson, A., Manguiat, K., et al. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1529134
La vacunación como estrategia para el control de la pandemia por SARS-CoV-2
Navarro-Alonso, J.-A. (2025) · Vacunas · doi:10.1016/j.vacun.2025.500429
Hybrid Immunity in a Mozambican Cohort After 1 or 2 Doses of the BBIBP-CorV Vaccine
Chissumba, R. M., Kwatra, G., Ramgi, P., Enosse, M., Sigaúque, A., Khosa, C., Viegas, E., Bule, O., Langa, J. P., Dhar, N., et al. (2025) · Clinical Infectious Diseases · doi:10.1093/cid/ciaf095 · Cited by 1
Vaccination as a strategy to control SARS-CoV-2 pandemic
Navarro-Alonso, J.-A. (2025) · Vacunas (English Edition) · doi:10.1016/j.vacune.2025.500429
Luvira, V., Lawpoolsri, S., Phumratanaprapin, W., Jongkaewwattana, A., Nanthapisal, S., Muangnoicharoen, S., Kamolratanakul, S., Sabmee, Y., Duangdee, C., Narakorn, P., et al. (2025) · Vaccine · doi:10.1016/j.vaccine.2025.127601
A three-dose MVA-BN mpox vaccination series improves the quality of anti-monkeypox virus immunityPreprint
Oom, A. L., Wilson, K. K., Rettig, S., Tuen, M., Samanovic, M. I., Kottkamp, A. C., Herati, R. S., Duerr, R., & Mulligan, M. J. (2025) · medRxiv · doi:10.1101/2025.10.31.25339252
Wangteeraprasert, A., Pongcharoen, S., Ngoenkam, J., & Makanut, S. (2025) · mSphere · doi:10.1128/msphere.00722-25
Baum, U., Poukka, E., Leino, T., Kilpi, T. M., Nohynek, H., & PALMU, A. A. I. (2022) · Figshare · doi:10.6084/m9.figshare.21510259
Tangsathapornpong, A., Kositamongkol, S., Angkasekwinai, P., Jaru-Ampornpan, P., Bunjoungmanee, P., Kulalert, P., Punyashthira, P., & Nanthapisal, S. (2026) · Vaccine X · doi:10.1016/j.jvacx.2026.100807
Chen, Y., Dong, C., Yan, W., Liu, Y., Sun, J., Ji, M., Gang, J., Nie, J., Zhang, X., Huang, H., et al. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.03.25.714088
Mechanisms underlying immunodynamics of layered defenses elicited by mRNA vaccination in children
Liao, Y., Chua, H. K., Lau, B. K., Wang, Y., Polak, F., Choi, A. N. X., Tay, C. J. X., Li, H., Shek, L., Tham, E. H., et al. (2026) · BMC Medicine · doi:10.1186/s12916-026-04852-6
Tang, Y. S., Chen, C. N., Lv, H., Sun, Y., Tan, C. W., Yiu, K., Ling, K. C., Chan, K., Mok, C. K. P., & Hui, D. S. C. (2026) · Vaccine · doi:10.1016/j.vaccine.2026.128634
Malaria serology for surveillance, insights into immunity, and vaccine development
Lim, P. S., Bernal, J., Karunarathne, J., & Longley, R. J. (2026) · Infection and Immunity · doi:10.1128/iai.00031-26 · Cited by 1
Time‐Resolved Multi‐Omics Identify Biomarkers of Immediate Reactions to mRNA Vaccination
Olivera, A., Schwarz, B. H., Dulek, B., LaCroix, I. S., Li, M., Chatman, L., Khalid, M. B., Zektser, E., Laky, K., Hartono, S. P., et al. (2026) · Allergy · doi:10.1111/all.70442
Recoding by N1-methylpseudouridine guides rational mRNA vaccine design
Poulis, P., Robecchi, G., Kurochkina, A., Felletti, M., & Rodnina, M. V. (2026) · Nature Communications · doi:10.1038/s41467-026-77796-3
Lee, C., Imran, I., Thomas, S., & Nouri-Shirazi, M. A. (2026) · Clinical Immunology Communications · doi:10.1016/j.clicom.2026.100144
Self-citation
Metadata
- Authors
- Payne, R. P., Longet, S., Austin, J. A., Skelly, D. T., Dejnirattisai, W., Adele, S., Meardon, N., Faustini, S., Al-Taei, S., Moore, S. C., Tipton, T., Hering, L. M., Angyal, A., Brown, R., Nicols, A. R., Gillson, N., Dobson, S. L., Amini, A., Supasa, P., Cross, A., Bridges-Webb, A., Reyes, L. S., Linder, A., Sandhar, G., Kilby, J. A., Tyerman, J. K., Altmann, T., Hornsby, H., Whitham, R., Phillips, E., Malone, T., Hargreaves, A., Shields, A., Saei, A., Foulkes, S., Stafford, L., Johnson, S., Wootton, D. G., Conlon, C. P., Jeffery, K., Matthews, P. C., Frater, J., Deeks, A. S., Pollard, A. J., Brown, A., Rowland-Jones, S. L., Mongkolsapaya, J., Barnes, E., Hopkins, S., Hall, V., Dold, C., Duncan, C. J. A., Richter, A., Carroll, M., Screaton, G., de Silva, T. I., Turtle, L., Klenerman, P., Dunachie, S., Abuelgasim, H., Adland, E., Adlou, S., Akther, H. D., Alhussni, A., Ali, M., Ansari, M. A., Arancibia-Cárcamo, C. V., Bayley, M., Brown, H., Chalk, J., Chand, M., Chawla, A., Chinnakannan, S., Cutteridge, J., de Lara, C., Denly, L., Diffey, B., Dimitriadis, S., Drake, T. M., Donnison, T., Dupont, M., Eyre, D., Fairman, A., Gardiner, S., Gilbert-Jarmillo, J., Goulder, P., Hackstein, C.-P., Hambleton, S., Haniffa, M., Haworth, J., Holmes, J., Horner, E., Jämsén, A., Johnson, S., Jones, C., Kasanyinga, M., Kelly, S., Kirk, R., Knight, M. L., Lawrie, A., Lee, L., Lett, L., Lillie, K., Lim, N., Mehta, H., Mentzer, A. J., O’Donnell, D., Ogbe, A., Pace, M., Payne, B. A. I., Platt, G., Poolan, S., Provine, N., Ramamurthy, N., Robinson, N., Romaniuk, L., Rongkard, P., Sampson, O. L., Simmons, B., Spegarova, J. S., Stephenson, E., Subramaniam, K., Thaventhiran, J., Thomas, S., Travis, S., Tucker, S., Turton, H., Watson, A., Watson, L., Weeks, E., Wilson, R., Wood, S., Wright, R., Xiao, H., & Zawia, A. A. T.
- Affiliations
- Newcastle University (GB)
- University of Liverpool (GB)
- University of Oxford (GB)
- Centre for Human Genetics (GB)
- Sheffield Teaching Hospitals NHS Foundation Trust (GB)
- University of Birmingham (GB)
- University of Sheffield (GB)
- Public Health England (GB)
- Liverpool University Hospitals NHS Foundation Trust (GB)
- Great North Children's Hospital (GB)
- University Hospitals Birmingham NHS Foundation Trust (GB)
- Oxford University Hospitals NHS Trust (GB)
- Siriraj Hospital (TH)
- Newcastle upon Tyne Hospitals NHS Foundation Trust (GB)
- Corresponding author
- Payne, Rebecca P.
- Klenerman, Paul
- ORCID
- Payne, Rebecca P.
- Austin, James A.
- Skelly, Donal T.
- Dejnirattisai, Wanwisa
- Adele, Sandra
- Faustini, Sian
- Moore, Shona C.
- Tipton, Tom
- Hering, Luisa M.
- Angyal, Adrienn
- Brown, Rebecca
- Nicols, Alexander R.
- Gillson, Natalie
- Dobson, Susan L.
- Amini, Ali
- Supasa, Piyada
- Reyes, Laura Silva
- Linder, Aline
- Tyerman, Jessica K.
- Altmann, Thomas
- Hornsby, Hailey
- Phillips, Eloise
- Hargreaves, Alexander
- Shields, Adrian
- Saei, Ayoub
- Foulkes, Sarah
- Stafford, Lizzie
- Conlon, Christopher P.
- Jeffery, Katie
- Matthews, Philippa C.
- Frater, John
- Deeks, Alexandra S.
- Pollard, Andrew J.
- Brown, Anthony
- Mongkolsapaya, Juthathip
- Barnes, Eleanor
- Hopkins, Susan
- Hall, Victoria
- Dold, Christina
- Duncan, Christopher J.A.
- Richter, Alex
- Carroll, Miles
- Screaton, Gavin
- de Silva, Thushan I.
- Turtle, Lance
- Klenerman, Paul
- Dunachie, Susanna
- Abuelgasim, Hibatullah
- Alhussni, Ahmed
- Ali, Mohammad
- Ansari, M. Azim
- Arancibia-Cárcamo, Carolina V.
- Chalk, Jeremy
- Chand, Meera
- Chinnakannan, Senthil
- Cutteridge, Joseph
- de Lara, Catherine
- Denly, Lucy
- Dimitriadis, Stavros
- Drake, Thomas M.
- Donnison, Timothy
- Dupont, Maeva
- Eyre, David
- Gardiner, Siobhan
- Goulder, Philip
- Hackstein, Carl-Philipp
- Hambleton, Sophie
- Haniffa, Muzlifah
- Holmes, Jennifer
- Horner, Emily
- Kasanyinga, Mwila
- Knight, Michael L.
- Lawrie, Allan
- Lee, Lian
- Lett, Lauren
- Lillie, Katy
- Lim, Nicholas
- Mentzer, Alexander J.
- Ogbe, Ane
- Pace, Matthew
- Payne, Brendan A.I.
- Platt, Gareth
- Provine, Nicholas
- Ramamurthy, Narayan
- Rongkard, Patpong
- Sampson, Oliver L.
- Spegarova, Jarmila S.
- Stephenson, Emily
- Thaventhiran, James
- Thomas, Sarah
- Travis, Simon
- Turton, Helena
- Watson, Adam
- Venue
- Cell
- Publisher
- Elsevier BV
- Published
- 2021-11
- Volume
- 184
- Issue
- 23
- Pages
- 5699-5714.e11
- ISSN
- 0092-8674 (ISSN-L)
- PMC
- PMC8519781
- OpenAlex
- W3206717788
- Cited by
- 322
- References
- 47
- Citations by year
- 2026: 14 · 2025: 33 · 2024: 34 · 2023: 87 · 2022: 135 · 2021: 18
- FWCI
- 21.70
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Cell (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- White Rose Research Online (University of Leeds, The University of Sheffield, University of York) (acceptedVersion)
- University of Birmingham Research Portal (University of Birmingham) (submittedVersion, cc-by)
- Greater South Information System
- Funders
- University of Liverpool
- Oxford University
- UK Research and Innovation
- Wellcome Trust (NIHR300791, 216417/Z/19/Z, 204721/Z/16/Z, 110058/Z/15/Z)
- U.S. Food and Drug Administration
- National Institute for Health Research
- Utah Department of Health
- Sheffield Teaching Hospitals NHS Foundation Trust
- Department of Health and Social Care
- University of Birmingham
- British Heart Foundation (FS/18/52/33808, PG/11/116/29288)
- Public Health England
- Topics
- Health Sciences › Medicine › Infectious Diseases › SARS-CoV-2 and COVID-19 Research
- Life Sciences › Immunology and Microbiology › Immunology › Immune responses and vaccinations
- Social Sciences › Health › Vaccine Coverage and Hesitancy
- Keywords
- BNT162b2 mRNA vaccine, extended dosing interval, single-dose vaccination, immunogenicity, neutralizing antibodies, spike protein, CD4+ T cells, interleukin-2, SARS-CoV-2, prior SARS-CoV-2 infection, healthcare workers
- MeSH terms
- COVID-19, SARS-CoV-2, COVID-19 Vaccines, mRNA Vaccines, BNT162 Vaccine, Adult, Aged, Antibodies, Viral, Dose-Response Relationship, Immunologic, Ethnicity, Female, Humans, Immunoglobulin G, Immunity, Male, Middle Aged, Reference Standards, T-Lymphocytes, Vaccines, Synthetic, Linear Models, Treatment Outcome, Cross-Priming, Young Adult, Antibodies, Neutralizing
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
